Allianz Asset Management Gmb H Albireo Pharma, Inc. Transaction History

Allianz Asset Management Gmb H

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$16.92 - $28.96 $271,599 - $464,865	-16,052 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$20.0 - $31.88 $466,080 - $742,931	-23,304 Reduced 59.21%	16,052 $321,000
Q2 2019 Aug 08, 2019	BUY	$30.67 - $37.86 $89,188 - $110,096	2,908 Added 7.98%	39,356 $1.27 Million
Q1 2019 May 13, 2019	SELL	$22.22 - $32.21 $12,665 - $18,359	-570 Reduced 1.54%	36,448 $1.17 Million
Q4 2018 Feb 14, 2019	SELL	$20.9 - $32.57 $30,743 - $47,910	-1,471 Reduced 3.82%	37,018 $908,000
Q3 2018 Nov 13, 2018	BUY	$29.29 - $36.87 $95,924 - $120,749	3,275 Added 9.3%	38,489 $1.27 Million
Q2 2018 Aug 13, 2018	BUY	$28.9 - $37.31 $1.02 Million - $1.31 Million	35,214 New	35,214 $1.25 Million

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.